These results were confirmed in an independent cohort of 35 patients, in which LTRs with a higher proportion of circulating CD4+CD25highFoxp3+ cells at 6 months had a higher risk of developing BOS in the next 3 years. Here, CD4 is linked to Buschke-Ollendorff syndrome.